Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
CFO Adam Laponis said he expects fiscal 2027 gross margin to still expand, despite about $15 million a year of depreciation, or about 2 to 3 points of headwind.
Expected fiscal 2027 AI drug discovery revenue assumption
$100 million, from programs it can forecast with high confidence
Expected fiscal 2027 and fiscal 2028 capital expenditures
approximately $150 million for capacity, automation and software, plus more than $30 million in landlord-funded tenant improvements
Expected fiscal 2027 depreciation on capital spending of about $75 million
Written by GetSignal with AI from each earnings call; every brief quotes the executives' own words. Key facts are what the company said on the call, not our forecast. Not investment advice.
Each firm's latest price target on TWST, newest first
Firm
Rating
Target
Action
Date
TD Cowen
Buy
$137
Target set
Canaccord
Buyrated Oct 12, 2026
$150
Target set
Jefferies
Not stated
$125
Target set
Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
6 other firms rated TWST in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 16, 2026.
Proxy statementas filed for fiscal 2025 · proxy filed Jan 6, 2026
Executive pay
Emily M. Leproust, Ph.D.’s pay as CEO came to $13.8M for fiscal 2025.
Executive
Salary
Stock awards
Other
Total
Emily M. Leproust, Ph.D.Chief Executive Officer and Chair of the Board
$720K
$12.0M
$1.1M
$13.8M
Patrick Finn, Ph.D.President and Chief Operating Officer
$563K
$6.7M
$711K
$8.0M
Adam LaponisChief Financial Officer
$490K
$3.4M
$361K
$4.2M
Dennis ChoChief Legal Officer and Corporate Secretary
$449K
$2.9M
$300K
$3.6M
Paula GreenSenior Vice President of Human Resources
$400K
$2.6M
$378K
$3.3M
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
13F filings13F positions as of Sep 30, 2026
Institutional holders
97 institutions reported Twist Bioscience shares in 13F filings for Sep 30, 2026.
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Sep 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
2 of the 97 fund managers we track list TWST shares among the largest positions in their latest 13F. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
STOCK Act2 disclosures of 2 on record · median 39d of the 45 allowed
Congress trades in TWST
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
+247.0%since the tradeEstimated entry price $32.16, close on Mon Mar 2, 2020Current price $111.60, close on Fri Nov 13
Mar 2, 2020
Apr 23, 2020
52d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on TWST show and how current they are.
Are insiders buying or selling TWST?
Across the 16 most recent open-market filings shown here, 0 were purchases and 16 were sales. 4 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded TWST?
Dwight Evans disclosed TWST transactions in the filings shown here.
How quickly are TWST trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.